Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18178159rdf:typepubmed:Citationlld:pubmed
pubmed-article:18178159lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C1955941lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:18178159lifeskim:mentionsumls-concept:C0348080lld:lifeskim
pubmed-article:18178159pubmed:issue2lld:pubmed
pubmed-article:18178159pubmed:dateCreated2008-1-24lld:pubmed
pubmed-article:18178159pubmed:abstractTextGeneration of effective CTL responses is the goal of many vaccination protocols. However, to what extant T cell precursor frequencies will generate a CD8(+) CTL response has not been elucidated properly. In this study, we employed a model system, in which naive CD4(+) and CD8(+) T cells derived from ovalbumin (OVA)-specific TCR transgenic OT II and OT I mice were used for adoptive transfer into wild-type, Ia(b-/-) gene knockout and transgenic RIP-mOVA mice, and assessed OVA-pulsed DC (DC(OVA))-stimulated CD8(+) CTL responses in these mice. We demonstrated that (i) a critical threshold exists above which T cells precursor frequency cannot enhance the CTL responses in wild-type C57BL/6 mice, (ii) increasing CD8(+) T cell precursors is required to generate CTL responses but with functional memory defect in absence of CD4(+) T cell help, and (iii) increasing CD4(+) and CD8(+) T cell precursors overcomes immune suppression to DC(OVA)-stimulated CD8(+) CTL responses in transgenic RIP-mOVA mice with OVA-specific self immune tolerance. Taken together, these findings may have important implications for optimizing immunotherapy against cancer.lld:pubmed
pubmed-article:18178159pubmed:languageenglld:pubmed
pubmed-article:18178159pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18178159pubmed:citationSubsetIMlld:pubmed
pubmed-article:18178159pubmed:statusMEDLINElld:pubmed
pubmed-article:18178159pubmed:monthMarlld:pubmed
pubmed-article:18178159pubmed:issn1090-2104lld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:XiangJimJlld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:YeZhenminZlld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:AhmedKhawaja...lld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:HuangJunqiong...lld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:XieYufengYlld:pubmed
pubmed-article:18178159pubmed:authorpubmed-author:MunegowdaManj...lld:pubmed
pubmed-article:18178159pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18178159pubmed:day7lld:pubmed
pubmed-article:18178159pubmed:volume367lld:pubmed
pubmed-article:18178159pubmed:ownerNLMlld:pubmed
pubmed-article:18178159pubmed:authorsCompleteYlld:pubmed
pubmed-article:18178159pubmed:pagination427-34lld:pubmed
pubmed-article:18178159pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:meshHeadingpubmed-meshheading:18178159...lld:pubmed
pubmed-article:18178159pubmed:year2008lld:pubmed
pubmed-article:18178159pubmed:articleTitleT cell precursor frequency differentially affects CTL responses under different immune conditions.lld:pubmed
pubmed-article:18178159pubmed:affiliationResearch Unit, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon, Saskatchewan, Canada.lld:pubmed
pubmed-article:18178159pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18178159pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14961entrezgene:pubmedpubmed-article:18178159lld:entrezgene